What's New

Last Posted: Jun 20, 2024

• 5-Year Real-World Outcomes With Frontline Pembrolizumab Monotherapy in PD-L1 Expression ≥ 50% Advanced NSCLC.
  Vamsidhar Velcheti et al. Clin Lung Cancer 2024
• Prevalence of Potentially Pathogenic Germline Variants Among Adult Patients in the Philippines With Solid Malignancies Who Underwent Tumor Genomic Profiling.
  Paula Isabel Franco et al. JCO Glob Oncol 2024 10e2400019
• Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice.
  Simon Garinet et al. Pathology 2024
• A deep learning-based radiomics model for predicting lymph node status from lung adenocarcinoma.
  Hui Xie et al. BMC Med Imaging 2024 24(1) 121
• Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell Lung Cancer.
  Jeanna Wallenta Law et al. JCO Precis Oncol 2024 8e2400075
• Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
  Umberto Malapelle et al. Br J Cancer 2024
• Leveraging Serial Low-Dose CT Scans in Radiomics-based Reinforcement Learning to Improve Early Diagnosis of Lung Cancer at Baseline Screening.
  Yifan Wang et al. Radiol Cardiothorac Imaging 2024 6(3) e230196
• The State of State Biomarker Testing Insurance Coverage Laws
  
• Trial of Electronic Medical Record Integrated Next-Generation Sequencing Ordering in Veterans Affairs Cancer Care.
  James H Stoeckle et al. JCO Precis Oncol 2024 8e2300463
• VLST: Virtual Lung Screening Trial for Lung Cancer Detection Using Virtual Imaging Trial.
  Fakrul Islam Tushar et al. ArXiv 2024
• Application of machine learning for lung cancer survival prognostication-A systematic review and meta-analysis.
  Alexander J Didier et al. Front Artif Intell 2024 71365777
• Application value of the automated machine learning model based on modified CT index combined with serological indices in the early prediction of lung cancer.
  Leyuan Meng et al. Front Public Health 2024 121368217
• Predicting the risk of lung cancer using machine learning: A large study based on UK Biobank.
  Siqi Zhang et al. Medicine (Baltimore) 2024 103(16) e37879
• Targeted next-generation sequencing of 491 lung cancers in clinical practice: Implications for future detection strategy and targeted therapy.
  Xiao-Dan Liu et al. Heliyon 2024 10(6) e27591
• Construction of a predictive model for bone metastasis from first primary lung adenocarcinoma within 3 cm based on machine learning algorithm: a retrospective study.
  Yu Zhang et al. PeerJ 2024 12e17098
• Telemedicine-Enhanced Lung Cancer Screening Using Mobile Computed Tomography Unit with Remote Artificial Intelligence Assistance in Underserved Communities: Initial Results of a Population Cohort Study in Western China.
  Wenjuan Tao et al. Telemed J E Health 2024
• Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC.
  Philip C Mack et al. Oncologist 2024
• Potential of radiomics analysis and machine learning for predicting brain metastasis in newly diagnosed lung cancer patients.
  S Yichu et al. Clin Radiol 2024
• NSCLC Digital PCR Panel Returns Low-Input Sample Results Where Sequencing Fails.
  Leah Rowland Herdt et al. Diagnostics (Basel) 2024 14(3)
• Exploring pollutant joint effects in disease through interpretable machine learning.
  Shuo Wang et al. J Hazard Mater 2024 467133707
• Genomic Landscape of NSCLC in the Republic of Ireland.
  Rachel J Keogh et al. JTO Clin Res Rep 2024 5(2) 100627
• Racial and ethnic disparities in genomic testing among lung cancer patients: a systematic review.
  Clare Meernik et al. J Natl Cancer Inst 2024 2
• Real-World Effectiveness of Lung Cancer Screening Using Deep Learning-Based Counterfactual Prediction.
  Zheng Feng et al. Stud Health Technol Inform 2024 310419-423
• Concurrent Circulating Tumor DNA and Tissue Genotyping-Ready for Prime Time?
  Benjamin A Bleiberg et al. JAMA Netw Open 2024 1 (1) e2351679
• Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort.
  Wade T Iams et al. JAMA Netw Open 2024 7(1) e2351700
• Editorial: World lung cancer awareness month 2022: artificial intelligence for clinical management of lung cancer.
  Parul Agarwal et al. Front Oncol 2024 131351016
• Predicting Phase 1 Lymphoma Clinical Trial Durations Using Machine Learning: An In-Depth Analysis and Broad Application Insights.
  Bowen Long et al. Clin Pract 2024 14(1) 69-88
• Benefits of Implementing Reflex Genomic Analysis for Nonsmall Cell Lung Cancer.
  Benjamin F Smith et al. J Appl Lab Med 2024 9(1) 28-40
• Comprehensive Genomic Analysis of Patients With Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan.
  Hsin-Yi Wang et al. JCO Precis Oncol 2024 8e2300314
• Effectiveness of next-generation sequencing for patients with advanced non-small-cell lung cancer: a population-based registry study.
  D-W Kang et al. ESMO Open 2024 9(1) 102200

More